Articles
Drug-induced movement disorders
My Health Record: a community pharmacy perspective
Editorial
Real-time prescription monitoring: lessons from Tasmania
Experimental and clinical pharmacology
Immune checkpoint inhibitors in malignancy
New drugs
Bictegravir/emtricitabine/tenofovir alafenamide for HIV infection
Ertugliflozin for type 2 diabetes
Midostaurin for acute myeloid leukaemia, mastocytosis and mast cell leukaemia
Nusinersen for spinal muscular atrophy
Safinamide for Parkinson’s disease
El número completo:
Australian Prescriber 2019; 42(2): 45-80.
Disponible en: http://bit.ly/2OHjwAs